- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1/L1 inhibitor plus anti-angiogenic agent
Total 3539 results
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced Hepatocellular CarcinomaChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingSafety Issues | Effect Increased
-
ImmunityBio, Inc.Active, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability | Mismatch Repair DeficiencyUnited States
-
Shandong Cancer Hospital and InstituteBeiGeneActive, not recruitingHepatocellular CarcinomaChina
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Swiss Group for Clinical Cancer ResearchCompletedNSCLC Non-small Cell Lung CancerSwitzerland
-
University of Colorado, DenverAstraZenecaWithdrawnPancreatic CancerUnited States
-
Gradalis, Inc.WithdrawnLung Neoplasms | Advanced Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Hunan Cancer... and other collaboratorsRecruitingNasopharyngeal Carcinoma | De-escalation TherapyChina
-
University of Colorado, DenverNational Cancer Institute (NCI); Cancer League of ColoradoWithdrawnColorectal Cancer | Microsatellite Instability High | Mismatch Repair DeficiencyUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
Dong WangNot yet recruiting
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
Johannes Gutenberg University MainzMerck KGaA, Darmstadt, GermanyCompleted
-
Tongji HospitalThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaboratorsRecruitingHepatocellular Carcinoma Non-resectableChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Chinese PLA General HospitalRecruitingGastric Cancer | Chemotherapy | Immunotherapy | Tumor MicroenvironmentChina
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Pd-1 InhibitorsChina
-
Chinese PLA General HospitalUnknownLymphoma | Solid TumorChina
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
Anwaar SaeedAstraZeneca; ExelixisActive, not recruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal AdenocarcinomaUnited States
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
AstraZenecaLaboratory Corporation of America; Medidata Solutions; IQVIA RDS Inc.; Calyx; Thermo... and other collaboratorsRecruitingErosive EsophagitisUnited States, Italy, Belgium, Vietnam, Spain, Portugal, Russian Federation, Argentina, Greece, Australia, Lithuania
-
SecuraBioTerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
Ze-yang Ding, MDGeneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)RecruitingCholangiocarcinoma Non-resectableChina
-
Chinese PLA General HospitalRecruitingDiffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Extranodal Extension | Relapse/RecurrenceChina
-
Chinese PLA General HospitalUnknownPrimary Mediastinal Large B-cell LymphomaChina
-
Wan-Guang ZhangThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaboratorsRecruitingHepatocellular Carcinoma Non-resectableChina
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
Hunan Cancer HospitalCompletedAnti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaChina
-
Fudan UniversityRecruiting
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina
-
Fundació Institut de Recerca de l'Hospital de la...Spanish Clinical Research Network - SCReNCompletedPreeclampsia | Intrauterine Growth RestrictionSpain
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Beijing Friendship HospitalRecruitingLocally Advanced Rectal CancerChina
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
St. Jude Children's Research HospitalPfizer; Gateway for Cancer ResearchCompletedOsteosarcomaUnited States
-
Beijing Friendship HospitalChanghai Hospital; Peking Union Medical College Hospital; Peking University Cancer...Not yet recruitingLocally Advanced Rectal CancerChina
-
PfizerViiV HealthcareCompletedHealthy VolunteersUnited States
-
Cancer Hospital of Guangxi Medical UniversityRecruitingNasopharyngeal Carcinoma | SintilimabChina
-
Xinqiao Hospital of ChongqingUnknownNon Small Cell Lung CancerChina
-
Beijing HospitalBethune Charitable FoundationRecruitingICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCMetastatic Colorectal Cancer | MSS | RAS MutationChina
-
Yehua ShenNot yet recruitingHCC - Hepatocellular Carcinoma
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Beijing Friendship HospitalCompleted
-
Shanghai Jiao Tong University School of MedicineRecruitingOral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFRChina